Galbraith Kenneth
Insider CIK 1567045 · MGNX Director · NONE Director · ZYME Chair, President & CEO, Director · ZYME Chair & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZYME Zymeworks Inc. | M Exercise deriv | 2026-01-12 | 2026-01-12 | 64,000 | — | $0 | 128,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2026-01-12 | 2026-01-12 | 144,000 | — | $0 | 144,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2026-01-12 | 2026-01-12 | 222,000 | — | $0 | 222,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2026-01-12 | 2026-01-12 | 216,000 | — | $0 | 216,000 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2026-01-12 | 2026-01-12 | 30,424 | $22.67 | $689.7K | 226,842 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2026-01-12 | 2026-01-12 | 64,000 | — | $0 | 257,266 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2026-01-05 | 2026-01-05 | 47,668 | — | $0 | 0 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2026-01-05 | 2026-01-05 | 66,666 | — | $0 | 66,668 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2026-01-05 | 2026-01-05 | 66,666 | — | $0 | 224,952 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2026-01-05 | 2026-01-05 | 22,657 | $25.10 | $568.7K | 158,286 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2026-01-05 | 2026-01-05 | 31,686 | $25.10 | $795.3K | 193,266 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2026-01-05 | 2026-01-05 | 47,668 | — | $0 | 180,943 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2025-12-22 | 2025-12-22 | 100,000 | — | $0 | 0 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2025-12-22 | 2025-12-22 | 100,000 | — | $0 | 180,803 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2025-12-22 | 2025-12-22 | 47,528 | $27.02 | $1.28M | 133,275 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2025-01-10 | 2025-01-10 | 192,000 | — | $0 | 192,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2025-01-10 | 2025-01-10 | 288,000 | — | $0 | 288,000 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2025-01-06 | 2025-01-06 | 47,666 | — | $0 | 47,668 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2025-01-06 | 2025-01-06 | 66,666 | — | $0 | 133,334 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2025-01-06 | 2025-01-06 | 47,666 | — | $0 | 71,428 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2025-01-06 | 2025-01-06 | 33,406 | $14.92 | $498.4K | 80,803 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2025-01-06 | 2025-01-06 | 66,666 | — | $0 | 114,209 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2025-01-06 | 2025-01-06 | 23,885 | $14.92 | $356.4K | 47,543 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2024-01-08 | 2024-01-08 | 5,706 | $11.22 | $64.0K | 23,762 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise deriv | 2024-01-05 | 2024-01-08 | 47,666 | — | $0 | 95,334 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2024-01-05 | 2024-01-08 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2024-01-05 | 2024-01-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2024-01-05 | 2024-01-08 | 18,198 | $10.65 | $193.8K | 29,468 | SEC↗ |
| ZYME Zymeworks Inc. | M Exercise | 2024-01-05 | 2024-01-08 | 47,666 | — | $0 | 47,666 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2023-01-05 | 2023-01-06 | 143,000 | — | $0 | 143,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2023-01-05 | 2023-01-06 | 215,000 | — | $0 | 215,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2022-12-22 | 2022-12-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2022-01-15 | 2022-01-18 | 500,000 | — | $0 | 500,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2021-05-13 | 2021-05-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise deriv | 2020-09-09 | 2020-09-10 | 6,924 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise deriv | 2020-09-09 | 2020-09-10 | 13,849 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | S Sale | 2020-09-09 | 2020-09-10 | 6,924 | $27.11 | $187.7K | 0 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise | 2020-09-09 | 2020-09-10 | 6,924 | $20.15 | $139.5K | 6,924 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise | 2020-09-09 | 2020-09-10 | 13,849 | $16.00 | $221.6K | 13,849 | SEC↗ |
| MGNX MACROGENICS INC | S Sale | 2020-09-09 | 2020-09-10 | 13,849 | $27.11 | $375.4K | 0 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2020-05-14 | 2020-05-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2019-05-16 | 2019-05-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2018-05-17 | 2018-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2017-05-18 | 2017-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2016-05-18 | 2016-05-20 | 8,500 | — | $0 | 8,500 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2015-05-20 | 2015-05-21 | 8,500 | — | $0 | 8,500 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2014-06-05 | 2014-06-09 | 6,924 | — | $0 | 6,924 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion deriv | 2013-10-16 | 2013-10-18 | 19,724,839 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | X Exercise deriv | 2013-10-16 | 2013-10-18 | 287,533 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion deriv | 2013-10-16 | 2013-10-18 | 3,833,767 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion | 2013-10-16 | 2013-10-18 | 1,050,652 | — | $0 | 1,097,527 | SEC↗ |
| MGNX MACROGENICS INC | P Buy | 2013-10-16 | 2013-10-18 | 46,875 | $16.00 | $750.0K | 46,875 | SEC↗ |
| MGNX MACROGENICS INC | C Conversion | 2013-10-16 | 2013-10-18 | 204,207 | — | $0 | 1,301,734 | SEC↗ |
| MGNX MACROGENICS INC | X Exercise | 2013-10-16 | 2013-10-18 | 15,315 | — | $0 | 1,317,049 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2013-10-09 | 2013-10-11 | 13,849 | — | $0 | 13,849 | SEC↗ |
| NONE Celator Pharmaceuticals In | A Award deriv | 2013-06-03 | 2013-06-04 | 28,000 | — | $0 | 28,000 | SEC↗ |